PH25149A - Cyclic peptides and their preparation - Google Patents

Cyclic peptides and their preparation

Info

Publication number
PH25149A
PH25149A PH36712A PH36712A PH25149A PH 25149 A PH25149 A PH 25149A PH 36712 A PH36712 A PH 36712A PH 36712 A PH36712 A PH 36712A PH 25149 A PH25149 A PH 25149A
Authority
PH
Philippines
Prior art keywords
preparation
cyclic peptides
peptides
cyclic
Prior art date
Application number
PH36712A
Other languages
English (en)
Inventor
Waleed Danho
Vincent Stewart Madison
Joseph Triscari
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH25149A publication Critical patent/PH25149A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PH36712A 1987-03-30 1988-03-29 Cyclic peptides and their preparation PH25149A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/031,632 US4808701A (en) 1987-03-30 1987-03-30 Cyclic peptides having appetite regulating activity

Publications (1)

Publication Number Publication Date
PH25149A true PH25149A (en) 1991-03-13

Family

ID=21860562

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36712A PH25149A (en) 1987-03-30 1988-03-29 Cyclic peptides and their preparation

Country Status (16)

Country Link
US (1) US4808701A (fr)
EP (1) EP0285061A3 (fr)
JP (1) JPS63258489A (fr)
KR (1) KR880011198A (fr)
AU (1) AU610144B2 (fr)
DK (1) DK174388A (fr)
FI (1) FI881470A (fr)
HU (1) HU201098B (fr)
IL (1) IL85885A0 (fr)
MC (1) MC1913A1 (fr)
NO (1) NO881384L (fr)
NZ (1) NZ224051A (fr)
PH (1) PH25149A (fr)
PT (1) PT87111B (fr)
YU (2) YU62688A (fr)
ZA (1) ZA881621B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086042A (en) * 1985-12-19 1992-02-04 Fisons Corporation Peptides with sulfate ester groups
FR2611722B1 (fr) * 1987-03-02 1989-08-11 Inst Nat Sante Rech Med Nouveaux peptides derives de la cck8, leur preparation et les compositions pharmaceutiques qui les contiennent
US5395823A (en) * 1988-08-26 1995-03-07 Merrell Dow Pharmaceuticals Inc. Neuropeptide Y agonists and partial agonists
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5270302A (en) * 1988-12-21 1993-12-14 Abbott Laboratories Derivatives of tetrapeptides as CCK agonists
DK0495013T3 (da) * 1989-11-27 1995-07-24 Astra Ab Hexapeptider med sulfatestergrupper
US5502164A (en) * 1989-11-27 1996-03-26 Fisons Corporation Peptide compounds having therapeutic activity
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US20030008843A1 (en) * 2001-04-09 2003-01-09 Shaw Craig Stuart Andrew Bulking agents as satiety agents
FI20020078A (fi) * 2002-01-15 2003-07-16 Danisco Immuunijärjestelmän stimulointi polydextroosilla
CN115353553B (zh) * 2022-06-27 2023-06-02 上海理工大学 一种靶向钙敏感受体的促cck分泌肽及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705140A (en) * 1967-10-05 1972-12-05 Luigi Bernardi Peptides related to the c-terminal sequence of cck-pz and caerulein
US3839315A (en) * 1968-05-03 1974-10-01 Squibb & Sons Inc Novel peptides having cholecystokinin activity and intermediates therefor
US4351289A (en) * 1980-08-06 1982-09-28 Renda Vince A Water injection system for internal combustion engines
US4351829A (en) * 1980-09-26 1982-09-28 Farmitalia Carlo Erba Spa Use of polypeptides as analgesic drugs
US4490364A (en) * 1983-05-20 1984-12-25 The Salk Institute For Biological Studies CCK Agonists II
NZ218607A (en) * 1985-12-19 1989-10-27 Pennwalt Corp Tri-to acta-peptides with sulphate ester groups: obesity treatment
ZA873796B (en) * 1986-06-06 1987-12-07 F. Hoffmann-La Roche & Co. Aktiengesellschaft Peptides

Also Published As

Publication number Publication date
MC1913A1 (fr) 1989-04-06
ZA881621B (en) 1988-11-30
AU1382488A (en) 1988-09-29
IL85885A0 (en) 1988-09-30
DK174388A (da) 1988-10-01
PT87111A (pt) 1988-04-01
YU62688A (en) 1989-10-31
FI881470A0 (fi) 1988-03-29
PT87111B (pt) 1992-07-31
DK174388D0 (da) 1988-03-29
EP0285061A2 (fr) 1988-10-05
HUT46709A (en) 1988-11-28
YU109089A (en) 1991-04-30
EP0285061A3 (fr) 1990-07-25
JPS63258489A (ja) 1988-10-25
KR880011198A (ko) 1988-10-27
US4808701A (en) 1989-02-28
NZ224051A (en) 1991-02-26
HU201098B (en) 1990-09-28
NO881384D0 (no) 1988-03-29
FI881470A (fi) 1988-10-01
AU610144B2 (en) 1991-05-16
NO881384L (no) 1988-10-03

Similar Documents

Publication Publication Date Title
ZA896767B (en) Cyclic grf-analogs ii
ZA881621B (en) Cyclic peptides and their preparation
GB2203740B (en) Novel peptides, their preparation and use
ZA878336B (en) Peptides
IL87730A0 (en) Peptides and antibodies
DE3760806D1 (en) Monohalogenotrifluorooxetane and its preparation
JPS6416798A (en) Peptide
JPS646295A (en) Anf-active peptide
IL81920A0 (en) Vaccines and their preparation
GB2193206B (en) Preparation of taurine-containing peptides
GB2194235B (en) Dichlorotrifluoromethyltoluenes and preparation thereof
ZA878945B (en) Peptides
ZA873796B (en) Peptides
IE871173L (en) Cyclic peptides
IL85375A0 (en) Cyclic peptides,their preparation and their use
JPS6431799A (en) Peptide and manufacture
IE883803L (en) Cyclic peptides
BG43444A1 (en) Peptides and method for their preparation
IL103741A0 (en) Amino compounds and their preparation
IE892847L (en) Cyclic peptides
IE872724L (en) Peptides and intermediates for their preparation
IE852910L (en) Cyclic peptides
GB8715863D0 (en) Peptides
IE880128L (en) Peptides
GB8715866D0 (en) Peptides